Acara Bioherb Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.95 Cr
- Revenue Growth -82.42%
- Profit Growth -181907.32%
- Ebitda -954.14%
- Net Worth -363.36%
- Total Assets -69.50%
About Acara Bioherb
Acara Bioherb Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 November 2012 and has a history of 12 years and three months. Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹8.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pawan Hanumanth and Holenarsipur Kumar serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233KA2012PTC066776
- Company No.
066776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Acara Bioherb Private Limited offer?
Acara Bioherb Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts.
Who are the key members and board of directors at Acara Bioherb?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Hanumanth  | Director | 16-Nov-2012 | Current |
| Holenarsipur Kumar | Director | 16-Nov-2012 | Current |
Financial Performance of Acara Bioherb.
Acara Bioherb Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 82.42% decrease. The company also saw a substantial fall in profitability, with a 181907.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 363.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acara Bioherb?
In 2023, Acara Bioherb had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.95 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 8.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2013 | State Bank Of India | ₹8.95 Cr | Satisfied |
How Many Employees Work at Acara Bioherb?
Unlock and access historical data on people associated with Acara Bioherb, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acara Bioherb, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acara Bioherb's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.